Surgical results in gastric cancer

Seminars in Surgical Oncology

Volumn 17, Issue 2, 1999, Pages 132-138

  Kim, Jin Pok ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

Adenocarcinoma; Combined anti neoplastic agents; Combined modality therapy; Gastrectomy; Jejunostomy; Local neoplasm recurrence; Lymph node excision; Lymph nodes surgery; Lymphatic metastasis; Neoplasm staging; Postoperative complications; Prognosis; Risk factors; Stomach neoplasms; Surgical anastomosis; Survival rate; Treatment outcome

Indexed keywords

DOXIFLURIDINE; FLUOROURACIL; PICIBANIL;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; GASTRECTOMY; GASTRECTOMY BILLROTH I; GASTRECTOMY BILLROTH II; HUMAN; JEJUNOSTOMY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANASTOMOSIS, SURGICAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; GASTROENTEROSTOMY; HUMANS; IMMUNOTHERAPY; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0032812302     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199909)17:2<132::AID-SSU8>3.0.CO;2-E     Document Type: Article

References (37)

1. Maruyama K: The most important prognostic factors for gastric cancer patients. A study using univariate and multivariate analysis. Scand J Gastroenterol Suppl 1987;22(#133):63-68.
2. Nakamura K, Ueyama T, Yao T, et al: Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy. Cancer 1992;70:1030-1037.
3. Kim JP, Kim YW, Yang HK, Noh DY: Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. World J Surg 1994;18:872-878.
4. Maruyama K, Okabayashi K, Kinoshita T: Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987;11:418-425.
5. Allum WH, Powell DJ, McConkey CC, Fielding JW: Gastric cancer: a 25-year review. Br J Surg 1989;76:535-540.
6. Akoh JA, MacIntyre IM: Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970 [Review]. Br J Surg 1992;79:293-299.
7. Wanebo HJ, Kennedy BJ, Chmiel J, et al: Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 1993;218:583-592.
8. Siewert JR, Bottcher K, Roder JD, et al: Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg 1993;80:1015-1018.
9. Roder JD, Bonenkamp JJ, Craven J, et al: Lymphadenectomy for gastric cancer in clinical trials: update [Review]. World J Surg 1995;19:546-553.
10. Lee WJ, Lee WC, Houng SJ, et al: Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: twenty years experience in Taiwan. World J Surg 1995;19:707-713.
11. Yang HK, Kang SB, Lee KU, et al: [Prognostic significance of the extent of lymph node dissection in gastric cancer]. J Korean Cancer Assoc 1997;29:198-203. (Kor)
12. Siewert JR, Kestlmeier R, Busch R, et al: Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 1996;83:1144-1147.
13. Roberston CS, Chung SC, Woods SD, et al: A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994;220:176-182.
14. Bonenkamp JJ, van de Velde CJ, Sasako M, Hermans J: R2 compared with R1 resection for gastric cancer: morbidity and mortality in a prospective, randomized trial. Eur J Surg 1992;158:413-418.
15. Bonenkamp JJ, Songun I, Hermans J, et al: Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345(8952):745-748.
16. Kim JP, Kwon OJ, Oh ST, Yang HK: Results of surgery on 6589 gastric cancer patients and immunochemosurgery as the best treatment of advanced gastric cancer. Ann Surg 1992;216:269-279.
17. Kim JP: The concept of immunochemosurgery in gastric cancer. World J Surg 1987; 11:465-472.
18. Harrison JD, Fielding JW: Prognostic factors for gastric cancer influencing clinical practice [Review]. World J Surg 1995;19:496-500.
19. Yu CC, Levison DA, Dunn JA, et al: Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer. Br J Cancer 1995;71:1106-1110.
20. rd, Dauterive AH, et al: Gastric carcinoma in the young. Cancer 1987;59:1362-1365.
21. Park JG, Gazdar AF, Kim YI, et al: Gastric cancer in Korea: experience at the Seoul National University Hospital. In Sugarbaker PH (ed): "Management of gastric cancer." Boston: Kluwer Academic; 1991 p. 285-305.
22. Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990;62:440-443.
23. Kim JP, Yoo HY, Kim SC, Yang HK: [Clinical analysis of gastric cardia cancer]. J Korean Cancer Assoc 1994;26:361-368. (Kor)
24. Hur YS, Yang HK, Kim JP: Factor analysis associated with lymph node metastasis in 1301 early gastric cancers. J Korean Surg Soc 1995;49:68-76. (Kor)
25. Kim JP, Jung SE: Patients with gastric cancer and their prognosis in accordance with number of lymph node metastases. Scand J Gastroenterol Suppl 1987;22(#133):33-35.
26. Kim JP, Yang HK, Oh ST: Is the new UICC staging system of gastric cancer reasonable? (Comparison of 5-year survival rate of gastric cancer by old and new UICC stage classification.) Surg Oncol 1992;1:209-213.
27. Ichikura T, Tomimatsu S, Okusa Y, et al: Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer. J Clin Oncol 1993;11:1894-1900.
28. Isozaki H, Okajima K, Kawashima Y, et al: Prognostic value of the number of metastatic lymph nodes in gastric cancer with radical surgery. J Surg Oncol 1993;53:247-251.
29. Adachi Y, Kamakura T, Mori M, et al: Prognostic significance of the number of positive lymph nodes in gastric carcinoma. Br J Surg 1994;81:414-416.
30. Sobin LH, Wittekind C (eds): "TNM classification of malignant tumours." 5th ed. New York: Wiley-Liss; 1997.
31. Yu W, Choi GS, Whang I, Suh IS: Comparison of five systems for staging lymph node metastasis in gastric cancer. Br J Surg 1997;84:1305-1309.
32. Okusa T, Nakane Y, Boku T, et al: Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surg Gynecol Obstet 1990;170:488-494.
33. Roder JD, Bottcher K. Siewert JR, et al: Prognostic factors in gastric carcinoma. Results of the German gastric carcinoma study 1992. Cancer 1993;72:2089-2097.
34. Juvan R, Repse S, Omejc M, et al: Prognostic value of lymph node metastasis ratio in gastric cancer. In: Siewert JR, Roder JD (eds): "Progress in gastric cancer research." Second International Gastric Cancer Congress; 1997 April 27-30; Munich, Germany, Bologna, Italy: Monduzzi Editore; 1997, p. 223-227.
35. Feinstein AR, Sosin DM, Wells CK: The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312: 1604-1608.
36. Byun JC, Lee JH, Kim SJ, et al: [Pancreatoduodenectomy for gastric cancer.] J Korean Cancer Assoc 1998;30:72-79. (Kor)
37. Wagner PK, Ramaswamy A, Ruschoff J, et al: Lymph node counts in the upper abdomen: anatomic basis for lymphadenectomy in gastric cancer. Br J Surg 1991;78:825-827.